MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

New Collaboration Agreement for the Production of Ultra High-Field 7.0-T MRI Systems

By MedImaging International staff writers
Posted on 20 May 2015
Print article
GE Healthcare (Chalfont St. Giles, UK) and Tesla Engineering (Pulborough; England) have announced that they will collaborate to produce 7.0-T human whole-body Magnetic Resonance Imaging (MRI) scanners.

Tesla Engineering, a cryogenics technology company, designs and manufactures resistive and superconducting electromagnets, and will build the 7.0-T magnets in a new factory under construction in Storrington (UK). The company plans to ship the first 7.0-T unit to GE Healthcare in late 2015.

Researchers use the ultra-high-field MRI scanners for scientific and medical research, especially for brain imaging. The research is intended to contribute to earlier detection, better diagnosis, and improved effectiveness for many medical disorders and diseases.

Richard Hausmann, president and CEO of GE Healthcare, said, “This agreement will enable GE to deepen and broaden our collaborations with leading MRI academics and visionaries, sharing our collective expertise and missions in technology, science and medicine. The GE 7.0-T community in the US, Europe and Asia has already demonstrated breakthrough observations and understanding of Alzheimer’s disease, traumatic brain injury and cognitive physiology. Together, we will continue to push the frontiers of MRI for neuroscience and other applications.”

Related Links:

GE Healthcare
Tesla Engineering 


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
Ultrasound Doppler System
Doppler BT-200
New
1.5T MRI System
uMR 670

Print article

Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more